News

Vanta Bioscience Limited informed the Bombay Stock Exchange that the trading window for transactions in the company`s shares will be closed for designated persons, their immediate relatives, and other concerned individuals, effective October 1, 2026, until 48 hours after the declaration of the company’s unaudited financial results for the half year ended September 30, 2026.

Vanta Bioscience Limited informed the BSE Limited that its board of directors approved the Annual Report for the financial year 2025-26 and fixed September 30, 2026, at 10:00 A.M. (IST) as the date, time, and venue for the 10th Annual General Meeting, with Mr. Zoheb S Sayani of Sayani & Associates appointed as the scrutinizer and Central Depository Services (India) Limited (CDSL) as the e-voting agency.

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Vanta Bioscience announced that the 9th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live News